tiprankstipranks
Trending News
More News >
Knight Therapeutics (KHTRF)
OTHER OTC:KHTRF
US Market

Knight Therapeutics (KHTRF) Financial Statements

Compare
32 Followers

Knight Therapeutics Financial Overview

Knight Therapeutics's market cap is currently $441.89M. The company's EPS TTM is $0.01458646; its P/E ratio is 56.30; Knight Therapeutics is scheduled to report earnings on May 8, 2025, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 371.30MC$ 328.20MC$ 293.56MC$ 243.48MC$ 199.52M
Gross ProfitC$ 174.41MC$ 152.65MC$ 138.06MC$ 115.41MC$ 81.69M
Operating IncomeC$ 7.40MC$ -2.89MC$ -2.40MC$ -5.32MC$ -3.44M
EBITDAC$ 64.38MC$ 40.90MC$ 25.26MC$ 42.59MC$ 67.56M
Net IncomeC$ 4.33MC$ -16.84MC$ -29.89MC$ 15.68MC$ 31.76M
Balance Sheet
Cash & Short-Term InvestmentsC$ 172.84MC$ 154.42MC$ 185.61MC$ 162.99MC$ 411.34M
Total AssetsC$ 963.80MC$ 945.49MC$ 1.05BC$ 991.89MC$ 1.04B
Total DebtC$ 49.46MC$ 69.09MC$ 77.70MC$ 40.96MC$ 56.19M
Net DebtC$ -30.65MC$ 10.33MC$ 6.02MC$ -45.01MC$ -173.40M
Total LiabilitiesC$ 168.69MC$ 198.62MC$ 228.98MC$ 149.87MC$ 153.44M
Stockholders' EquityC$ 795.11MC$ 746.87MC$ 825.86MC$ 842.02MC$ 886.24M
Cash Flow
Free Cash FlowC$ 4.81MC$ 25.98MC$ 14.66MC$ -179.56MC$ -32.87M
Operating Cash FlowC$ 36.28MC$ 35.94MC$ 40.48MC$ 44.62MC$ -12.21M
Investing Cash FlowC$ 16.96MC$ 29.34MC$ -63.08MC$ -105.28MC$ 101.35M
Financing Cash FlowC$ -33.54MC$ -81.00MC$ 1.76MC$ -78.31MC$ -29.23M
Currency in CAD

Knight Therapeutics Earnings and Revenue History

Knight Therapeutics Debt to Assets

Knight Therapeutics Cash Flow

Knight Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis